Also known as: reduced nicotinamide mononucleotide, dihydronicotinamide mononucleotide, NMN reduced form
Strongest in Recency (100). Held back by Sample size (5).
Solid mix of RCTs with some methodological gaps.
Few independent replications; results not yet robust.
Small combined sample; treat as preliminary.
Studies agree on direction of effect.
Most studies are recent (last 2-3 years).
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
Recommended: 250-500mg daily
A two-minute quiz builds a daily plan of habits, diet and supplements around your goals and what you already take. Free, no account needed.
Start the quizProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.